QRG Capital Management Inc. Raises Position in Integer Holdings Co. (NYSE:ITGR)

QRG Capital Management Inc. lifted its position in Integer Holdings Co. (NYSE:ITGR) by 1.1% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 31,368 shares of the medical equipment provider’s stock after buying an additional 332 shares during the period. QRG Capital Management Inc. owned about 0.09% of Integer worth $3,660,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Blue Trust Inc. lifted its position in Integer by 483.3% in the 4th quarter. Blue Trust Inc. now owns 455 shares of the medical equipment provider’s stock valued at $45,000 after acquiring an additional 377 shares in the last quarter. Principal Securities Inc. bought a new position in shares of Integer during the fourth quarter valued at $67,000. Headlands Technologies LLC bought a new stake in Integer in the 1st quarter worth about $106,000. Quadrant Capital Group LLC raised its position in Integer by 10.2% in the 4th quarter. Quadrant Capital Group LLC now owns 1,427 shares of the medical equipment provider’s stock worth $141,000 after buying an additional 132 shares during the last quarter. Finally, Strs Ohio raised its holdings in shares of Integer by 54.5% during the fourth quarter. Strs Ohio now owns 1,700 shares of the medical equipment provider’s stock valued at $168,000 after purchasing an additional 600 shares during the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Price Performance

ITGR traded up $4.87 during trading on Tuesday, hitting $124.77. 446,142 shares of the company traded hands, compared to its average volume of 316,949. The company has a current ratio of 3.32, a quick ratio of 2.01 and a debt-to-equity ratio of 0.76. Integer Holdings Co. has a 1 year low of $69.40 and a 1 year high of $125.57. The stock’s 50-day simple moving average is $117.54 and its two-hundred day simple moving average is $111.78. The company has a market cap of $4.18 billion, a PE ratio of 41.48, a P/E/G ratio of 1.78 and a beta of 1.11.

Integer (NYSE:ITGR) last posted its earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share for the quarter, beating analysts’ consensus estimates of $1.12 by $0.02. The firm had revenue of $414.80 million during the quarter, compared to analyst estimates of $412.78 million. Integer had a net margin of 6.01% and a return on equity of 11.25%. Integer’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same period last year, the firm posted $0.87 earnings per share. As a group, sell-side analysts anticipate that Integer Holdings Co. will post 5.27 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ITGR has been the topic of several research reports. Citigroup raised their target price on Integer from $118.00 to $124.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 22nd. Oppenheimer initiated coverage on Integer in a research note on Tuesday. They issued an “outperform” rating and a $135.00 price objective on the stock. Benchmark reiterated a “buy” rating and set a $130.00 price objective on shares of Integer in a research note on Friday, May 10th. Truist Financial started coverage on shares of Integer in a research note on Wednesday, May 15th. They set a “buy” rating and a $137.00 target price on the stock. Finally, Bank of America upgraded shares of Integer from a “neutral” rating to a “buy” rating and upped their price target for the stock from $105.00 to $135.00 in a research report on Monday, April 15th. Three investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, Integer currently has a consensus rating of “Moderate Buy” and an average target price of $128.88.

Insider Transactions at Integer

In related news, EVP John A. Harris sold 1,521 shares of the stock in a transaction dated Tuesday, June 4th. The shares were sold at an average price of $120.44, for a total value of $183,189.24. Following the sale, the executive vice president now directly owns 4,922 shares of the company’s stock, valued at approximately $592,805.68. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Integer news, EVP John A. Harris sold 1,521 shares of the company’s stock in a transaction dated Tuesday, June 4th. The shares were sold at an average price of $120.44, for a total value of $183,189.24. Following the transaction, the executive vice president now directly owns 4,922 shares in the company, valued at approximately $592,805.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director James F. Hinrichs sold 9,603 shares of Integer stock in a transaction that occurred on Friday, May 24th. The shares were sold at an average price of $122.44, for a total transaction of $1,175,791.32. Following the sale, the director now directly owns 7,424 shares of the company’s stock, valued at approximately $908,994.56. The disclosure for this sale can be found here. Insiders have sold a total of 17,936 shares of company stock worth $2,130,937 in the last three months. Insiders own 2.00% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.